Close Navigation
About ArixStrategy
OverviewInvestment CaseNewsResultsDocumentsEventsCalendarAnalystsStock infoContact
AboutStrategyTeamPortfolioInsightsMediaContact
Investors
AboutStrategyTeamPortfolioInsightsMediaContact
Investors
Overlay

Team

Experienced and collaborative team, with diverse and complementary backgrounds. The investment team have deep scientific and commercial expertise

The Arix Team

Roy Bartel-Taverner, MD

Analyst

Felix Breyer, PhD

Associate

Laura Craig

Investor Relations Officer

Tom Davidson

Finance Director

Jade Fletcher

Financial Controller

Tassos Konstantinou

Managing Director

Robert Lyne

CEO

Board of Directors

Peregrine Moncreiffe

Chairman

Debra Barker, MD

Senior Independent Director

Isaac Kohlberg

Non-Executive Director

Maureen O’Connell

Non-Executive Director

Andrew Smith

Non-Executive Director

Arix Bioscience

About Arix

The Team

Portfolio

Insights

News & Events

Contact

Investor Relations

Results Centre

Financial Calendar

Regulatory News

Document Library

Analysts & Advisors

Shareholder Information

Meta

Privacy Policy

Terms of use

Cookie Policy

Stay up to date

Sign up to receive regulatory news and results

Subscribe
Arix Bioscience
linkedintwitter

Arix Bioscience plc, registered in England and Wales with company number 09777975

Registered office: Duke Street House, 50 Duke Street, London, W1K 6JL, United Kingdom

Website by Ether